secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTENSITY THERAPEUTICS, INC. (INTS)
CIK:        0001567264
Form:       8-K
Filed at:   2026-03-23T23:59:59+00:00
Accession:  0001567264-26-000021
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Intensity Therapeutics expands at-the-market offering capacity to $60 million
-----------------------------------------------------------------------------

- Filed prospectus supplement on March 23, 2026 to increase ATM program from prior cap to $60.0 million aggregate.
- ATM conducted through H.C. Wainwright & Co. as sales agent under agreement dated July 3, 2024.
- Company has no obligation to sell any shares; issuances at its discretion based on market conditions.
- Expanded facility aims to enhance financial flexibility for strategic priorities and capital access.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1567264/000156726426000021/0001567264-26-000021-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1567264/000156726426000021/intensity-20260323.htm
  HTML page:      https://secwatch.observer/filing/0001567264-26-000021

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer